feed,title,long_url,short_url
Benzinga,FDA Approves Drug to Reduce Bone Marrow Suppression Caused by Chemotherapy,https://www.benzinga.com/pressreleases/21/02/n19651045/fda-approves-drug-to-reduce-bone-marrow-suppression-caused-by-chemotherapy,https://j.mp/3d5TIvR
Benzinga,Outlook on the Sustainable Athleisure Global Market to 2026 - Industry Analysis and Forecasts,https://www.benzinga.com/pressreleases/21/02/n19651044/outlook-on-the-sustainable-athleisure-global-market-to-2026-industry-analysis-and-forecasts,https://j.mp/3tRVNBJ
Benzinga,Exelixis Announces Final Phase 1 Results from Clinical Trial Sponsored by the National Cancer Institute at ASCO GU for Cabozantinib in Combination with Nivolumab with or without Ipilimumab in Patients with Refractory Metastatic Genitourinary Tumors,https://www.benzinga.com/pressreleases/21/02/b19651040/exelixis-announces-final-phase-1-results-from-clinical-trial-sponsored-by-the-national-cancer-inst,https://j.mp/3d8Z6hO
Benzinga,"West Mountain, Devin Singletary Announce First-Ever Tuber Bowl For 2022",https://www.benzinga.com/pressreleases/21/02/n19650920/west-mountain-devin-singletary-announce-first-ever-tuber-bowl-for-2022,https://j.mp/3qtMiGV
